Hybio Pharmaceutical Co., Ltd., a hi-tech enterprise specialized in the R&D and manufacturing of diverse peptides, founded in 2003, is one of pioneers who are firstly dedicated in peptide field in China. Hybio was also the first listed peptide company in China and we are the only one that has a full range of peptide products and services, including peptide finished dosage products, peptide API products, and peptide CRO&CMO services.
API facility has been approved by USFDA, EU and also KFDA;
FD facility has been approved by EU, ANVISA and Indonesia MOH